ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,671,443 | -18.2% | 1,224,118 | +0.7% | 0.10% | -9.8% |
| Q2 2023 | $8,156,173 | -21.0% | 1,215,525 | +3.9% | 0.11% | -34.5% |
| Q1 2023 | $10,326,862 | -61.0% | 1,169,520 | +24.1% | 0.17% | +13.2% |
| Q4 2021 | $26,451,000 | -60.5% | 942,666 | -52.1% | 0.15% | -56.5% |
| Q3 2021 | $66,951,000 | -20.1% | 1,969,726 | -3.9% | 0.35% | -15.6% |
| Q2 2021 | $83,762,000 | -12.7% | 2,049,963 | -14.0% | 0.41% | -20.5% |
| Q1 2021 | $95,988,000 | -31.6% | 2,384,205 | +0.4% | 0.52% | -25.8% |
| Q4 2020 | $140,422,000 | +20.5% | 2,374,798 | -0.9% | 0.70% | -2.9% |
| Q3 2020 | $116,580,000 | -1.9% | 2,397,279 | -2.4% | 0.72% | -22.7% |
| Q2 2020 | $118,786,000 | +87.6% | 2,455,269 | +7.7% | 0.93% | +22.4% |
| Q1 2020 | $63,318,000 | +169.5% | 2,279,250 | +190.3% | 0.76% | +211.1% |
| Q4 2019 | $23,493,000 | -4.1% | 785,198 | -0.9% | 0.24% | -13.2% |
| Q3 2019 | $24,492,000 | -14.3% | 792,621 | +33.9% | 0.28% | -2.4% |
| Q2 2019 | $28,581,000 | – | 591,749 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |